APA

Paz-Ares L., Bálint B., de Boer R. H., van Meerbeeck J. P., Wierzbicki R., De Souza P., Galimi F., Haddad V., Sabin T., Hei Y., Pan Y., Cottrell S., Hsu C. & RamLau R. (20130730). A randomized phase 2 study of paclitaxel and carboplatin with or without conatumumab for first-line treatment of advanced non-small-cell lung cancer. : Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Chicago

Paz-Ares Luis, Bálint Beatrix, de Boer Richard H, van Meerbeeck Jan P, Wierzbicki Rafal, De Souza Paul, Galimi Francesco, Haddad Vincent, Sabin Tony, Hei Yong-jiang, Pan Yang, Cottrell Susan, Hsu Cheng-Pang and RamLau Rodryg. 20130730. A randomized phase 2 study of paclitaxel and carboplatin with or without conatumumab for first-line treatment of advanced non-small-cell lung cancer. : Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Harvard

Paz-Ares L., Bálint B., de Boer R. H., van Meerbeeck J. P., Wierzbicki R., De Souza P., Galimi F., Haddad V., Sabin T., Hei Y., Pan Y., Cottrell S., Hsu C. and RamLau R. (20130730). A randomized phase 2 study of paclitaxel and carboplatin with or without conatumumab for first-line treatment of advanced non-small-cell lung cancer. : Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

MLA

Paz-Ares Luis, Bálint Beatrix, de Boer Richard H, van Meerbeeck Jan P, Wierzbicki Rafal, De Souza Paul, Galimi Francesco, Haddad Vincent, Sabin Tony, Hei Yong-jiang, Pan Yang, Cottrell Susan, Hsu Cheng-Pang and RamLau Rodryg. A randomized phase 2 study of paclitaxel and carboplatin with or without conatumumab for first-line treatment of advanced non-small-cell lung cancer. : Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 20130730.